Roche's MDx Sales Rise 8 Percent in Q1 | GenomeWeb

This article has been updated with additional information from Roche's earnings call and slide presentation.

NEW YORK (GenomeWeb) – Roche today reported an 8 percent increase in first quarter sales for its molecular diagnostics business year over year, driven by strong growth for its HPV testing products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.